Cargando…

Wanted: Class VI Antiarrhythmic Drug Action; New Start for a Rational Drug Therapy

Detalles Bibliográficos
Autores principales:	Karagueuzian, Hrayr S, Klein, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508654/ https://www.ncbi.nlm.nih.gov/pubmed/31080887 http://dx.doi.org/10.16966/2379-769X.148

Ejemplares similares

Enhanced Late Na and Ca Currents as Effective Antiarrhythmic Drug Targets
por: Karagueuzian, Hrayr S., et al.
Publicado: (2017)

Initiation and outcomes with Class Ic antiarrhythmic drug therapy
por: Gao, Xu, et al.
Publicado: (2017)

A mathematical model to understand the mechanisms of action of class 1 antiarrhythmic drugs
por: Jain, Dinesh K., et al.
Publicado: (2010)

Recent Advances in Antiarrhythmic Drug Therapy
por: Saljic, Arnela, et al.
Publicado: (2023)

Optimal antiarrhythmic drug therapy for electrical storm
por: Sorajja, Dan, et al.
Publicado: (2015)

The Future of Antiarrhythmic Drug Therapy: Will Drugs Be Entirely Replaced by Procedures?
por: Valderrábano, Miguel
Publicado: (2022)

Effects of Antiarrhythmic Drugs on Antiepileptic Drug Action—A Critical Review of Experimental Findings
por: Borowicz-Reutt, Kinga K.
Publicado: (2022)

Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery disease
por: Pantlin, Peter G., et al.
Publicado: (2020)

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018)

Current and Emerging Antiarrhythmic Drug Therapy for Ventricular Tachycardia
por: Williams, Eric S., et al.
Publicado: (2013)

Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Gaine, Sean P., et al.
Publicado: (2023)

Use of antiarrhythmic drugs in elderly patients
por: Lee, Hon-Chi, et al.
Publicado: (2011)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

Clinically Important Drug–Drug Interactions Between Antiarrhythmic Drugs and Anticoagulants
por: Konieczny, Kaja M., et al.
Publicado: (2019)

Cardiac Arrhythmias and Antiarrhythmic Drugs: An Autophagic Perspective
por: van Bavel, Joanne J. A., et al.
Publicado: (2018)

Reduced-dose Antiarrhythmic Drugs: Valuable or Valueless?
por: Reiffel, James A.
Publicado: (2020)

Antiarrhythmic Drug Dosing in Children—Review of the Literature
por: Oeffl, Nathalie, et al.
Publicado: (2023)

Class III antiarrhythmic drugs amiodarone and dronedarone impair K(IR)2.1 backward trafficking
por: Ji, Yuan, et al.
Publicado: (2017)

Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation
por: Wang, Amy
Publicado: (2012)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018)

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

The Antiarrhythmic Drug Flecainide Enhances Aversion to HCl in Mice
por: Kawabata, Yuko, et al.
Publicado: (2023)

Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation
por: Verrier, Richard L., et al.
Publicado: (2020)

Oxidative stress, fibrosis, and early afterdepolarization-mediated cardiac arrhythmias
por: Karagueuzian, Hrayr S., et al.
Publicado: (2013)

ARumenamides: A novel class of potential antiarrhythmic compounds
por: Abdelsayed, Mena, et al.
Publicado: (2022)

Class III Antiarrhythmics and Periprocedural Torsades de Pointes
por: Font, Cristina M., et al.
Publicado: (2023)

Influence of dronedarone (a class III antiarrhythmic drug) on the anticonvulsant potency of four classical antiepileptic drugs in the tonic–clonic seizure model in mice
por: Sawicka, Katarzyna M., et al.
Publicado: (2018)

Comparison of Circumferential Pulmonary Vein Isolation and Antiarrhythmic Drug Therapy in Patients with Atrial Fibrillation
por: Xu, Yanmin, et al.
Publicado: (2012)

Editorial: Perspectives of Antiarrhythmic Drug Therapy: Disappointing Past, Current Efforts, and Faint Hopes
por: Nánási, Péter P., et al.
Publicado: (2020)

Evaluation of Index of Cardio-Electrophysiological Balance in Patients With Atrial Fibrillation on Antiarrhythmic-Drug Therapy
por: Afsin, Abdulmecit, et al.
Publicado: (2021)

Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation
por: Winkle, Roger A., et al.
Publicado: (2012)

Facilitated electrical cardioversion: does the selection of the antiarrhythmic drug matter?
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2019)

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
por: Hwang, Inseok, et al.
Publicado: (2021)

Can Artemisinin Be a Game Changer Even as an Antiarrhythmic Drug?
por: Hwang, Jongmin
Publicado: (2023)

Drug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamine
por: Kuypers, K. P. C., et al.
Publicado: (2018)

Mechanisms Underlying the Antiarrhythmic Action of Compound ALM-802
por: Tsorin, I. B., et al.
Publicado: (2023)

Clinical implications from the European Heart Rhythm Association consensus document on antiarrhythmic drug therapy
por: Özcan, Emin Evren, et al.
Publicado: (2018)

Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms
por: Geng, Meng, et al.
Publicado: (2020)

Correction to: Evaluation of Index of Cardio-Electrophysiological Balance in Patients With Atrial Fibrillation on Antiarrhythmic-Drug Therapy
por: Afsin, Abdulmecit, et al.
Publicado: (2021)

Meta‐analysis of cryoballoon ablation versus antiarrhythmic drugs as initial therapy for symptomatic atrial fibrillation
por: Mao, Yin‐jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4ol2176gjrld0na8cts8bg4i1p